The developing landscape of therapeutic therapy demands a reassessment of established approaches. Present research is altering focus towards tailored treatment plans, incorporating genomics, proteomics, and other sophisticated biomarkers to predict patient response and lessen adverse reactions. This nascent paradigm emphasizes precise interventions